April 2008

Posted on April 25, 2008 at 3:09 PM
Filed under: Corporate Dealmaker | Dealscape | The Deal Calendar

The Deal's video calendar for the week of April 28th, with updates on BofA/Countrywide, XM/Sirius and more. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 8, 2008 at 3:01 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

A partner at Weil, Gotshal & Manges, Fiona Schaeffer specializes in antitrust counseling, litigation and transactional matters. She is also a vice chair of the International Antitrust Committee of the ABA's Section of Antitrust Law; and a co-chair of the International Antitrust Committee of the ABA's Section of International Law. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 8, 2008 at 2:40 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

David P. Wales is Deputy Director of the Federal Trade Commission's Bureau of Competition. Prior to joining the FTC, he was a partner in the antitrust practice group of Cadwalader, Wickersham & Taft LLP, handling antitrust litigation, mergers and acquisitions, joint ventures, distribution arrangements, competitor collaborations and grand jury investigations. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 8, 2008 at 10:36 AM
Filed under: Behind the Money | Tech Confidential

Andrew Viterbi, a co-founder of Qualcomm Inc. spoke with us just moments after he was named one of the finalists for the 2008 Millennium Technology Prize. In Tech Confidential's exclusive Behind the Money video interview, Viterbi talks about his work as a communications pioneer, including his involvement in commercializing the Code Division Multiple Access, or CDMA, mobile phone standard -- and about the communications companies he invests in currently as president of venture capital firm Viterbi Group LLC. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 7, 2008 at 2:56 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

Richard J. Zall is a partner at Proskauer Rose LLP and Chair of the firm's Health Industry practice group. His practice is focused on corporate and regulatory representation of health care clients, including academic medical centers, hospitals, and physician organizations; information technology and medical device companies; managed care and health benefit management companies; and private equity firms.  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 7, 2008 at 2:32 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

David Wales, Deputy Director, of the Bureau of Competition Federal Trade Commission discusses how the federal trade commission evaluates hospital mergers and pharmaceutical mergers and its ongoing investigations at The Deal's Healthcare Dealmaking Symposium.  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 5, 2008 at 2:15 PM
Filed under: Corporate Dealmaker | Healthcare Symposium | The Deal's Events

Chul Pak is a partner at Wilson Sonsini, Goodrich & Rosati and a former assistant director of the Mergers IV Division at the Federal Trade Commission. In this clip Pak discussses the regulatory outlook for healthcare deals over the next year at The Healthcare Dealmaking Symposium.  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 4, 2008 at 4:42 PM
Filed under: Corporate Dealmaker | Healthcare Symposium | The Deal's Events

Prior to Omnicare, Christine Arakelian led corporate development positions at Neighborcare and Alpharma. She is a corporate and licensing attorney, with a J.D. from the University of Virginia and a B.A. with honors from the University of Pennsylvania. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 4, 2008 at 2:34 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

A Principal at KKR, Nathaniel Zilkha focuses on investments in healthcare. Prior to joining KKR, he led the healthcare investing efforts for the Goldman Sachs Capital Partners funds. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 3, 2008 at 4:25 PM
Filed under: Corporate Dealmaker | Healthcare Symposium | The Deal's Events

Omnicare's Arakelian on the advantages deep-pocketed strategic buyers are enjoying due to the credit crunch at The Deal's Healthcare Dealmaking Symposium. Continue reading

[ Share ]  [ E-mail]  [ Comments (1) ]  [ Full Story ]